Cargando…
PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
BACKGROUND: Prostate cancer is a highly prevalent urological carcinoma with an increasing incidence in Indonesia and all around the world. Early diagnosis can greatly affect treatment outcomes and increase life expectancy. Several biomarkers for detecting prostate cancer have been studied and showed...
Autores principales: | Warli, Syah Mirsya, Warli, Muhammad Haritsyah, Prapiska, Fauriski Febrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167967/ https://www.ncbi.nlm.nih.gov/pubmed/37181497 http://dx.doi.org/10.2147/RRU.S401131 |
Ejemplares similares
-
P53 and Survival Rate in Penile Cancer
por: Prapiska, Fauriski Febrian, et al.
Publicado: (2019) -
Evaluation of Paclitaxel, Ifosfamide, and Cisplatin (TIP) Regimen on Penile Cancer in Adam Malik Medan: A Single Center 2 Years of Experience
por: Sitompul, Ardiansyah Periadi, et al.
Publicado: (2019) -
Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients
por: Warli, Syah Mirsya, et al.
Publicado: (2022) -
Systemic Inflammatory Response in Predicting Prostate Cancer: The Diagnostic Value of Neutrophil-To-Lymphocyte Ratio
por: Adhyatma, Kharisma Prasetya, et al.
Publicado: (2019) -
Poor prognosis of urothelial carcinoma in patients presented with persistent paraneoplastic leukocytosis with anemia
por: Warli, Syah Mirsya, et al.
Publicado: (2022)